Is ACHV or ACTU more undervalued in 2026?

CirclFi compares Achieve Life Sciences, Inc. (ACHV) and Actuate Therapeutics, Inc. (ACTU) using 13 institutional-grade valuation models. ACHV has a Quality of Company score of 4.3/10 while ACTU scores 3.7/10.

Which is a better buy — ACHV or ACTU?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ACHV and ACTU valuations compare?

ACHV at $5.30 and ACTU at $2.08 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ACHV vs ACTU Valuation Comparison 2026 — Intrinsic Value Analysis

ACHV

Biotechnology

Achieve Life Sciences, Inc.

Quality

4.3

out of 10

Value Trap

LOW

Price

$5.30

Last close

Models

7/13

Active

ACTU

Biotechnology

Actuate Therapeutics, Inc.

Quality

3.7

out of 10

Value Trap

SAFE

Price

$2.08

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	ACHV Fair Value	ACHV Upside	ACTU Fair Value	ACTU Upside
Bayesian DCF	Intrinsic	$1.57	-70.5%	$0.74	-64.6%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.41	-92.3%	$0.85	-59.2%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ACHV vs ACTU — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ACHV vs ACTU — Which Stock Is More Undervalued?

ACHV scores higher with a 4.3/10 quality rating vs ACTU's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Achieve Life Sciences, Inc. (ACHV) and Actuate Therapeutics, Inc. (ACTU) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ACHV currently trades at $5.30 with a QOC of 4.3/10, while ACTU trades at $2.08 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).